A group of doctors today filed suit against the Food & Drug Administration for failing to alert diabetes patients to safer alternatives to Avandia and other diabetes drugs that may increase the risk of stroke, heart attack and death. Avandia manufacturer GlaxoSmithKline faces more than 13,000 suits for hiding the drug's heart attack risks. The FDA is currently reviewing the drug, and is holding a special joint meeting of two advisory panels today and Wednesday to determine whether to pull Avandia from the market.
July 13, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A group of doctors today filed suit against the Food & Drug Administration for failing to alert diabetes patients to safer alternatives to Avandia and other diabetes drugs that may increase the risk of stroke, heart attack and death.
The suit, filed in U.S. District Court for the District of Columbia by the non-profit Physicians Committee for Responsible Medicine, faults FDA Commissioner Margaret Hamburg for failing to act on the group’s 2007 petition.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
